Rapport Therapeutics, Inc. · NASDAQ:RAPP

Cormorant Asset Management, LP reported a 6.19% stake in Rapport Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Cormorant Asset Management, LP reported a 6.19% stake in Rapport Therapeutics, Inc., 2,957,521 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
6.19%
Shares
2,957,521
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Cormorant Asset Management, LP6.19%2,957,521
Bihua Chen6.19%2,957,521

Source

View original at SEC

Related